Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (640)	2/26/2007 8:02:05 PM
From: zeta1961	Read Replies (1) \| Respond to of 802

While some make it their past time to gotcha INGN, Gendicine, according to this British news video, has by now treated 4500 patients with a 6 year follow-up..Sibiono is building a plant with million dose capacity, and a 50 bed wing is being added to one of the hospitals to accomodate foreign patients.. It should be remembered that China has 80% of the world wide head and neck cancer patients..lung cancer is in epidemic proportions..imo, it would behoove INGN to make a deal with them.. channel4.com The 2005 International Gene Therapy organization had their conference in China..I wish I were a fly on the wall in the breakout sessions!